Tufts Health Plan provides positive coverage decision and in-network provider status
bioTheranostics, a leading provider of molecular diagnostic solutions for cancer, has received a positive coverage decision and in-network provider status from Tufts Health Plan for its CancerTYPE ID molecular cancer classifier.
Linear Mode
